Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells-Reference-Cited by-同舟云学术

Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells

Published:2019-10-01 Issue:10 Volume:30 Page:1284-1296
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Zhang L.¹²,Rossi A.³⁴,Lange L.³⁵,Meumann N.¹³,Koitzsch U.¹²,Christie K.⁶,Nesbit M.A.⁶,Moore C.B.T.⁶⁷,Hacker U.T.³⁸,Morgan M.³⁵,Hoffmann D.³⁵,Zengel J.⁹,Carette J.E.⁹,Schambach A.³⁵¹⁰,Salvetti A.⁴,Odenthal M.¹²,Büning H.¹³⁵¹¹

Affiliation:

1. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany

2. Institute of Pathology, University Hospital of Cologne, Cologne, Germany

3. Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany

4. International Center for Research in Infectiology (CIRI), INSERM U1111, CNRS UMR5308, Lyon, France

5. REBIRTH Cluster of Excellence, Hannover Medical School, Hannover, Germany

6. Biomedical Sciences Research Institute, Ulster University, Ulster, Northern Ireland

7. Avellino Labs USA, Menlo Park, California

8. 1st Medical Department, University Cancer Center Leipzig, University Leipzig Medical Center, Leipzig, Germany

9. Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California

10. Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts

11. German Center for Infection Research (DZIF), Partner Sites Bonn-Cologne and Hannover-Braunschweig, Braunschweig, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/hum.2019.027

Reference55 articles.

1. Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution

2. Next-generation AAV vectors—do not judge a virus (only) by its cover

3. Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?

4. Emerging Issues in AAV-Mediated In Vivo Gene Therapy

5. Engineering the AAV capsid to optimize vector–host-interactions

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive power of deleterious single amino acid changes to infer on AAV2 and AAV2-13 capsids fitness;Molecular Therapy - Methods & Clinical Development;2024-09

2. Inhibiting endothelial Rhoj blocks profibrotic vascular intussusception and angiocrine factors to sustain lung regeneration;Science Translational Medicine;2024-08-28

3. Dopaminylation of endothelial TPI1 suppresses ferroptotic angiocrine signals to promote lung regeneration over fibrosis;Cell Metabolism;2024-08

4. Delivery of DNA-Based Therapeutics for Treatment of Chronic Diseases;Pharmaceutics;2024-04-13

5. Exploration of the Noncoding Genome for Human-Specific Therapeutic Targets—Recent Insights at Molecular and Cellular Level;Cells;2023-11-20